English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: The objective of this study is to compare the effi cacy as well as safety profile of hydralazine and labetalol in severe hypertension of pregnancy. Methodology: Hundred (100) women with severe pregnancy induced hypertension were randomly alloca ted into two groups of 50 each. Study group was given intravenous hydralazine and control group was treated with labetalol. The efficacy of two drugs were noted in terms of time taken to achieve target bloo d pressure, number of doses required and number of patients developing severe persistent hypertension. Results: The average time taken to control blood pressure (BP) in hydralazine group was 32.66 ± 18.7 9 minutes and 30.70 ± 20.46 minutes in labetalol group and this was statistically significant (p<0.0 01).There was no statistical difference between the two drugs in terms of efficacy, perinatal outcome and a dverse affect except headache which was significant ly more in hydralazine group. Conclusion: Both hydralazine and labetalol can be used to trea t hypertensive emergencies.

A comparative study of intravenous hydralazine versus labetalol in the management of severe hypertension in pregnancy